Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease
Clinical and Molecular Hepatology · 01.07.2024 · 30 (3) · 449-467
DOI: 10.3350/cmh.2024.0047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2024. Verfasst von Yiyuan Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Sha…. Hauptthemen laut MEDLINE: Ursolic Acid, Triterpenes, Th17 Cells, Osteopontin. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Background/Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become an increasingly important health challenge, with a substantial rise linked to changing lifestyles and global obesity. Ursolic acid, a natural pentacyclic triterpenoid, has been explored for its potential therapeutic effects. Given its multifunctional bioactive properties, this research further revealed the pharmacological mechanisms of ursolic acid on MASLD.
Methods
Drug target chips and bioinformatics analysis were combined in this study to explore the potential therapeutic effects of ursolic acid on MASLD. Molecular docking simulations, surface plasmon resonance analyses, pull-down experiments, and co-immunoprecipitation assays were used to verify the direct interactions. Gene knockdown mice were generated, and high-fat diets were used to validate drug efficacy. Furthermore, initial CD4+ T cells were isolated and stimulated to demonstrate our findings.
Results
In this study, the multifunctional extracellular matrix phosphorylated glycoprotein secreted phosphoprotein 1 (SPP1) was investigated, highlighting its capability to induce Th17 cell differentiation, amplifying inflammatory cascades, and subsequently promoting the evolution of MASLD. In addition, this study revealed that in addition to the canonical TGF-β/IL-6 cytokine pathway, SPP1 can directly interact with ITGB1 and CD44, orchestrating Th17 cell differentiation via their joint downstream ERK signaling pathway. Remarkably, ursolic acid intervention notably suppressed the protein activity of SPP1, suggesting a promising avenue for ameliorating the immunoinflammatory trajectory in MASLD progression.
Conclusions
Ursolic acid could improve immune inflammation in MASLD by modulating SPP1-mediated Th17 cell differentiation via the ERK signaling pathway, which is orchestrated jointly by ITGB1 and CD44, emerging as a linchpin in this molecular cascade.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Department of Spleen, Stomach and Hepatobiliary, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, China.
- Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Department of Gastroenterology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Shanghai Municipal Health Commission
- China Postdoctoral Science Foundation
- Shanghai Medical Innovation & Development Foundation
- Guangdong Province Traditional Chinese Platform Construction
Zitieren
APA
Zheng, Y., Zhao, L., Xiong, Z., Huang, C., Yong, Q., Fang, D., Fu, Y., Gu, S., Chen, C., Li, J., Zhu, Y., Liu, J., Liu, F., & Li, Y. (2024). Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology, 30(3), 449-467. https://doi.org/10.3350/cmh.2024.0047
Vancouver
Zheng Y, Zhao L, Xiong Z, Huang C, Yong Q, Fang D, et al. Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 2024;30(3):449-467. doi:10.3350/cmh.2024.0047
BibTeX
@article{Zheng2024,
author = {Zheng, Yiyuan and Zhao, Lina and Xiong, Zhekun and Huang, Chaoyuan and Yong, Qiuhong and Fang, Dan and Fu, Yugang and Gu, Simin and Chen, Chong and Li, Jiacheng and Zhu, Yingying and Liu, Jing and Liu, Fengbin and Li, Yong},
title = {Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease},
journal = {Clinical and Molecular Hepatology},
year = {2024},
volume = {30},
number = {3},
pages = {449--467},
doi = {10.3350/cmh.2024.0047}
}
EUVIMED